(Q41846912)

13 October 2017

Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee (English)

1 reference

13 October 2017

phase I clinical trial

0 references

phase II clinical trial

0 references

author name string

Rubens RD

1

1 reference

13 October 2017

Kaye SB

2

1 reference

13 October 2017

Soukop M

3

1 reference

13 October 2017

Williams CJ

4

1 reference

13 October 2017

Brampton MH

5

1 reference

13 October 2017

Harris AL

6

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 December 1991

1 reference

British Journal of Cancer

13 October 2017

1 reference

13 October 2017

64

1 reference

13 October 2017

6

1 reference

13 October 2017

1187-1188

1 reference

Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas.

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977835

Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977835

Assessment of response to therapy in advanced breast cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977835

New ribonucleotide reductase inhibitors with antineoplastic activity

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977835

5 June 2018

Identifiers

DOI

10.1038/BJC.1991.488

1 reference

Dimensions Publication ID

13 October 2017

0 references

1 reference

13 October 2017

PubMed publication ID

1764386

1 reference